Gilles AMSALLEM

Gilles Amsallem is Chief Executive Officer of Biométhodes.
He is an entrepreneur with 25 years of corporate, technology and business development experience in the field of biotechnology acquired in various countries while working for companies such as SNIA Sorin Biomedica, Litton Bionetics, Dupont, Biocon and Avesthagen. Furthermore, he co-founded Mixis Genetics, a start-up company for drug discovery and development, which he sold to Pfizer after seven years.
Gilles Amsallem joined Biométhodes in 2007 and restructured the company, initially specialized in the field of therapeutic proteins optimization, into a leading player of second generation biorefineries and green chemistry.